These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Urinary TIMP-2 and IGFBP7 for the prediction of acute kidney injury following cardiac surgery. Wang Y; Zou Z; Jin J; Teng J; Xu J; Shen B; Jiang W; Zhuang Y; Liu L; Luo Z; Wang C; Ding X BMC Nephrol; 2017 May; 18(1):177. PubMed ID: 28558754 [TBL] [Abstract][Full Text] [Related]
5. Urinary TIMP-2 and IGFBP7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery. Meersch M; Schmidt C; Van Aken H; Martens S; Rossaint J; Singbartl K; Görlich D; Kellum JA; Zarbock A PLoS One; 2014; 9(3):e93460. PubMed ID: 24675717 [TBL] [Abstract][Full Text] [Related]
6. Urinary Biomarkers IGFBP7 and TIMP-2 for the Diagnostic Assessment of Transient and Persistent Acute Kidney Injury in Critically Ill Patients. Daubin D; Cristol JP; Dupuy AM; Kuster N; Besnard N; Platon L; Buzançais A; Brunot V; Garnier F; Jonquet O; Klouche K PLoS One; 2017; 12(1):e0169674. PubMed ID: 28085896 [TBL] [Abstract][Full Text] [Related]
7. Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. Bihorac A; Chawla LS; Shaw AD; Al-Khafaji A; Davison DL; Demuth GE; Fitzgerald R; Gong MN; Graham DD; Gunnerson K; Heung M; Jortani S; Kleerup E; Koyner JL; Krell K; Letourneau J; Lissauer M; Miner J; Nguyen HB; Ortega LM; Self WH; Sellman R; Shi J; Straseski J; Szalados JE; Wilber ST; Walker MG; Wilson J; Wunderink R; Zimmerman J; Kellum JA Am J Respir Crit Care Med; 2014 Apr; 189(8):932-9. PubMed ID: 24559465 [TBL] [Abstract][Full Text] [Related]
8. Routine Adoption of Urinary [IGFBP7]∙[TIMP-2] to Assess Acute Kidney Injury at Any Stage 12 hours After Intensive Care Unit Admission: a Prospective Cohort Study. Ferrari F; Romero-González G; Topete LR; Senzolo M; Lorenzin A; Husain-Syed F; Puci MV; Ferraro OE; Muraro E; Serrano-Soto M; Triviño AM; Castro AC; Xie Y; Yang B; De Cal M; Corradi V; Brendolan A; Scarpa M; Carta MR; Giavarina D; Bonato R; Ronco C Sci Rep; 2019 Nov; 9(1):16484. PubMed ID: 31712687 [TBL] [Abstract][Full Text] [Related]
9. Urinary biomarkers TIMP-2 and IGFBP7 early predict acute kidney injury after major surgery. Gocze I; Koch M; Renner P; Zeman F; Graf BM; Dahlke MH; Nerlich M; Schlitt HJ; Kellum JA; Bein T PLoS One; 2015; 10(3):e0120863. PubMed ID: 25798585 [TBL] [Abstract][Full Text] [Related]
11. The effectiveness of urinary TIMP-2 and IGFBP-7 in predicting acute kidney injury in critically ill neonates. Chen J; Sun Y; Wang S; Dai X; Huang H; Bai Z; Li X; Wang J; Li Y Pediatr Res; 2020 May; 87(6):1052-1059. PubMed ID: 31791043 [TBL] [Abstract][Full Text] [Related]
12. Intraoperative prediction of cardiac surgery-associated acute kidney injury using urinary biomarkers of cell cycle arrest. Cummings JJ; Shaw AD; Shi J; Lopez MG; O'Neal JB; Billings FT J Thorac Cardiovasc Surg; 2019 Apr; 157(4):1545-1553.e5. PubMed ID: 30389130 [TBL] [Abstract][Full Text] [Related]
13. Economic and clinical benefits of early identification of acute kidney injury using a urinary biomarker. Berdugo MA; Kirson NY; Zimmer L; Beyhaghi H; Toback S; Scarpati LM; Stone MN; Dember R; Tseng-Tham J; Wen J; Miller M J Med Econ; 2019 Dec; 22(12):1281-1289. PubMed ID: 31234668 [No Abstract] [Full Text] [Related]
14. Serial Urinary Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 and the Prognosis for Acute Kidney Injury over the Course of Critical Illness. McCullough PA; Ostermann M; Forni LG; Bihorac A; Koyner JL; Chawla LS; Shi J; Kampf JP; McPherson P; Kellum JA; Cardiorenal Med; 2019; 9(6):358-369. PubMed ID: 31618746 [TBL] [Abstract][Full Text] [Related]
15. Epidemiology of acute kidney injury and the role of urinary [TIMP-2]·[IGFBP7]: a prospective cohort study in critically ill obstetric patients. Tyagi A; Luthra A; Kumar M; Das S Int J Obstet Anesth; 2018 Nov; 36():77-84. PubMed ID: 30245258 [TBL] [Abstract][Full Text] [Related]
16. Real-World Use of AKI Biomarkers: A Quality Improvement Project Using Urinary Tissue Inhibitor Metalloprotease-2 and Insulin-Like Growth Factor Binding Protein 7 ([TIMP-2]*[IGFBP7]). La AM; Gunning S; Trevino SA; Kunczt A; Forni LG; Swamy V; Zarbock A; Groboske S; Leung EKY; Yeo KJ; Koyner JL Am J Nephrol; 2023; 54(7-8):281-290. PubMed ID: 37356428 [TBL] [Abstract][Full Text] [Related]
17. Interventions, Barriers, and Proposed Solutions Associated With the Implementation of a Protocol That Uses Clinical Decision Support and a Stress Biomarker Test to Identify ICU Patients at High-Risk for Drug Associated Acute Kidney Injury. Williams VL; Smithburger PL; Imhoff AN; Groetzinger LM; Culley CM; Burke CX; Murugan R; Lamberty PE; Mahmud M; Benedict NJ; Kellum JA; Kane-Gill SL Ann Pharmacother; 2023 Apr; 57(4):408-415. PubMed ID: 35962583 [TBL] [Abstract][Full Text] [Related]
18. Urinary [TIMP-2] × [IGFBP7] for risk prediction of acute kidney injury in decompensated heart failure. Schanz M; Shi J; Wasser C; Alscher MD; Kimmel M Clin Cardiol; 2017 Jul; 40(7):485-491. PubMed ID: 28295429 [TBL] [Abstract][Full Text] [Related]
20. Current understanding and future directions in the application of TIMP-2 and IGFBP7 in AKI clinical practice. Fan W; Ankawi G; Zhang J; Digvijay K; Giavarina D; Yin Y; Ronco C Clin Chem Lab Med; 2019 Apr; 57(5):567-576. PubMed ID: 30179848 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]